Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Koss

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Journal of Neurochemistry|April 21, 2019
In vitro models of synucleinopathies: informing on molecular mechanisms and protective strategiesAmir Tayaranian Marvian, David J Koss, Farhang Aliakbari, et al.
Acta Neuropathologica|October 23, 2016
Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive declineDavid J Koss, Glynn Jones, Anna Cranston, et al.
Molecular Neurobiology|August 10, 2019
Knock-in of Mutated hTAU Causes Insulin Resistance, Inflammation and Proteostasis Disturbance in a Mouse Model of Frontotemporal DementiaClaire Hull, Ruta Dekeryte, David J Koss, et al.
Molecular Neurobiology|June 10, 2020
Synaptic Loss, ER Stress and Neuro-Inflammation Emerge Late in the Lateral Temporal Cortex and Associate with Progressive Tau Pathology in Alzheimer's DiseaseHeather Buchanan, Murray Mackay, Kerri Palmer, et al.
Brain Pathology (Zurich, Switzerland)|August 8, 2020
RAB39B is redistributed in dementia with Lewy bodies and is sequestered within aβ plaques and Lewy bodiesDavid J Koss, Odeta Bondarevaite, Sara Adams, et al.
Neurobiology of Disease|March 8, 2016
Mutant Tau knock-in mice display frontotemporal dementia relevant behaviour and histopathologyDavid J Koss, Lianne Robinson, Benjamin D Drever, et al.
Acta Neuropathologica Communications|July 6, 2022
Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodiesDavid J Koss, Daniel Erskine, Andrew Porter, et al.
Acta Neuropathologica|February 14, 2024
Regional AT-8 reactive tau species correlate with intracellular Aβ levels in cases of low AD neuropathologic changeNauman Malik, Mohi-Uddin Miah, Alessandro Galgani, et al.
BMC Pharmacology|February 6, 2007
A comparative study of the actions of alkylpyridinium salts from a marine sponge and related synthetic compounds in rat cultured hippocampal neuronesDavid J Koss, Kathleen P Hindley, Kanola C David, et al.
Molecular Neurodegeneration|January 23, 2019
Dementia with Lewy bodies: an update and outlookTiago Fleming Outeiro, David J Koss, Daniel Erskine, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Journal of Neurochemistry|April 21, 2019
In vitro models of synucleinopathies: informing on molecular mechanisms and protective strategiesAmir Tayaranian Marvian, David J Koss, Farhang Aliakbari, et al.
Acta Neuropathologica|October 23, 2016
Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive declineDavid J Koss, Glynn Jones, Anna Cranston, et al.
Molecular Neurobiology|August 10, 2019
Knock-in of Mutated hTAU Causes Insulin Resistance, Inflammation and Proteostasis Disturbance in a Mouse Model of Frontotemporal DementiaClaire Hull, Ruta Dekeryte, David J Koss, et al.
Molecular Neurobiology|June 10, 2020
Synaptic Loss, ER Stress and Neuro-Inflammation Emerge Late in the Lateral Temporal Cortex and Associate with Progressive Tau Pathology in Alzheimer's DiseaseHeather Buchanan, Murray Mackay, Kerri Palmer, et al.
Brain Pathology (Zurich, Switzerland)|August 8, 2020
RAB39B is redistributed in dementia with Lewy bodies and is sequestered within aβ plaques and Lewy bodiesDavid J Koss, Odeta Bondarevaite, Sara Adams, et al.
Neurobiology of Disease|March 8, 2016
Mutant Tau knock-in mice display frontotemporal dementia relevant behaviour and histopathologyDavid J Koss, Lianne Robinson, Benjamin D Drever, et al.
Acta Neuropathologica Communications|July 6, 2022
Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodiesDavid J Koss, Daniel Erskine, Andrew Porter, et al.
Acta Neuropathologica|February 14, 2024
Regional AT-8 reactive tau species correlate with intracellular Aβ levels in cases of low AD neuropathologic changeNauman Malik, Mohi-Uddin Miah, Alessandro Galgani, et al.
BMC Pharmacology|February 6, 2007
A comparative study of the actions of alkylpyridinium salts from a marine sponge and related synthetic compounds in rat cultured hippocampal neuronesDavid J Koss, Kathleen P Hindley, Kanola C David, et al.
Molecular Neurodegeneration|January 23, 2019
Dementia with Lewy bodies: an update and outlookTiago Fleming Outeiro, David J Koss, Daniel Erskine, et al.
Pageof 3